In 2018, the FDA recognized the potential clinical benefits that certain psychedelics might offer. As a result, they listed one such agent, psilocybin, and a “fast-track” drug that could be researched for clinical use. Since that time, there have been several studies that support psilocybin treatment for a variety of conditions. Common ones include depression, […] The post The Surprising Market for Psilocybin appeared first on Bold Business.
